[Federal Register Volume 62, Number 181 (Thursday, September 18, 1997)]
[Rules and Regulations]
[Pages 48939-48940]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-24736]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 510


New Animal Drugs; Change of Sponsor Address

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect a change of sponsor address for K. C. 
Pharmacal, Inc.

EFFECTIVE DATE: September 18, 1997.

FOR FURTHER INFORMATION CONTACT: Judith O'Haro, Center for Veterinary 
Medicine (HFV-6), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 301-827-3664.

SUPPLEMENTARY INFORMATION: K. C. Pharmacal, Inc., 1310 Atlantic, P.O. 
Box 7496, North Kansas City, MO 64116, has informed FDA of a change of 
sponsor address to K. C. Pharmacal, Inc., 8345 Melrose Dr., Lenexa, KS 
66214. Accordingly, the agency is amending the regulations in 21 CFR 
510.600(c)(1) and (c)(2) to reflect the change of sponsor address.

List of Subjects in 21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.
    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is 
amended as follows:

 PART 510--NEW ANIMAL DRUGS

    1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority:  Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352, 
353, 360b, 371, 379e).

    2. Section 510.600 is amended in the table in paragraph (c)(1) by 
revising the sponsor address for ``K. C. Pharmacal, Inc.'' and in the 
table in paragraph (c)(2) in the entry for ``038782'' by revising the 
sponsor address to read as follows:


Sec. 510.600   Names, addresses, and drug labeler codes of sponsors of 
approved applications.

* * * * *
    (c) *  *  *
    (1) *   *   *

                                                                        
------------------------------------------------------------------------
          Firm name and address                  Drug labeler code      
------------------------------------------------------------------------
  *                  *                  *                  *            
                   *                  *                  *              
K. C. Pharmacal, Inc., 8345 Melrose Dr.,  038782                        
 Lenexa, KS 66214.                                                      
  *                  *                  *                  *            
                   *                  *                  *              
------------------------------------------------------------------------

    (2) *   *   *

[[Page 48940]]



                                                                        
------------------------------------------------------------------------
            Drug labeler code                  Firm name and address    
------------------------------------------------------------------------
  *                  *                  *                  *            
                   *                  *                  *              
038782...................................  K. C. Pharmacal, Inc., 8345  
                                            Melrose Dr., Lenexa, KS     
                                            66214                       
  *                  *                  *                  *            
                   *                  *                  *              
------------------------------------------------------------------------


    Dated: September 4, 1997.
George A. Mitchell,
Acting Director, Center for Veterinary Medicine.
[FR Doc. 97-24736 Filed 9-17-97; 8:45 am]
BILLING CODE 4160-01-F